Literature DB >> 6104299

Treatment of acute pancreatitis with somatostatin.

B Limberg, B Kommerell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104299     DOI: 10.1056/NEJM198007313030517

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

2.  Effects of somatostatin on acute canine experimental pancreatitis.

Authors:  D E Schlarman; M C Beinfeld; C Andrus; D L Kaminski
Journal:  Int J Pancreatol       Date:  1987-08

3.  A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.

Authors:  W Uhl; M W Büchler; P Malfertheiner; H G Beger; G Adler; W Gaus
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Drug Therapy for Acute Pancreatitis.

Authors:  Yan Bi; Tegpal Atwal; Santhi Swaroop Vege
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

5.  Octreotide ameliorates glucose intolerance following acute experimental pancreatitis.

Authors:  B Avni; R Haddad; H Kashtan; D Kaplan; E Graf; A Siegal; Y Skornick; O Kaplan
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

6.  Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis.

Authors:  B van Ooijen; C J Tinga; W J Kort; F J Zijlstra; S W Lamberts; J H Wilson
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

Review 7.  Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.

Authors:  M W Büchler; M Binder; H Friess
Journal:  Gut       Date:  1994       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.